Apoptosis is involved in the senescence of endothelial cells induced by angiotensin II

Cell Biology International

Volumn 32, Issue 2, 2008, Pages 264-270

  Shan, Hai Yan ^a   Bai, Xiao Juan ^a   Chen, Xiang Mei ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Angiotensin II; Apoptosis; Atherosclerosis; Endothelial cell; Senescence; Ultrastructure

Indexed keywords

ANGIOTENSIN II; BETA GALACTOSIDASE;

APOPTOSIS; ARTICLE; CELL AGING; CELL CYCLE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL SHAPE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FRAGMENTATION REACTION; HUMAN; HUMAN CELL; MICRONUCLEUS; PHENOTYPE; SENESCENCE; STAINING; VASCULAR ENDOTHELIUM;

ANGIOTENSIN II; APOPTOSIS; BIOLOGICAL MARKERS; CELL AGING; CELL CYCLE; CELL LINE; CELL SHAPE; CELL SURVIVAL; ENDOTHELIAL CELLS; HUMANS; STAINING AND LABELING;

EID: 39749200115     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2007.09.003     Document Type: Article

References (34)

1. Asai K., Kudej R.K., Shen Y.T., Yang G.P., Takagi G., Kudej A.B., et al. Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler Thromb Vasc Biol 20 (2000) 1493-1499
2. Brandes R.P., Fleming I., and Zeiher A.M. Apoptosis of endothelial cells. Cardiovasc Res 66 (2005) 286-294
3. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120 (2005) 513-522
4. Chen H., Li D., and Mehta J.L. Modulation of matrix metalloproteinase-1, its tissue inhibitor, and nuclear factor-kappB by losartan in hypercholesterolemic rabbits. Cardiovasc Pharmacol 39 (2002) 2579-2587
5. Copper L.T., Cooke J.P., and Dzau V.J. The vasculaopathy of aging. J Gerontol 49 (1994) B191-B196
6. Csiszar A., Ungvari Z., Edwards J.G., Kaminski P.M., Wolin M.S., Koller A., et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res 90 (2002) 1159-1166
7. Dimmeler S., Haendeler J., and Zeiher A.M. Regulation of endothelial cell apoptosis in atherothrombosis. Curr Opin Lipidol 13 (2002) 531-536
8. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., et al. A biomarker that identifies senescence human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92 (1995) 9363-9367
9. Docherty J.R. Cardiovascular responses in aging: a review. Pharmacol Rev 42 (1990) 103-125
10. Dohi Y., Kojima M., Sato K., and Lüscher T.F. Age-related changes in vascular smooth muscle and endothelium. Drug Aging 7 (1995) 278-291
11. Ferrari A.U., Radaelli A., and Centola M. Invited review: aging and the cardiovascular system. J Appl Physiol 95 (2003) 2591-2597
12. Folkow B., and Svanborg A. Physiology of cardiovascular aging. Physiol Rev 73 (1993) 725-734
13. Foreman K.E., and Tang J. Molecular mechanisms of replicative senescence in endothelial cells. Exp Gerontol 38 (2003) 1251-1257
14. Heymes C., Swynghedauw B., and Chevalier B. Activation of angiotensin and angiotensin converting enzyme gene expression in the left ventricle of senescent rats. Circulation 90 (1998) 1328-1333
15. Heymes C., Silverstre J.S., Cortes C.L., Chevalier B., Marotte F., Levy B., et al. Cardiac senescence is associated with enhanced expression of angiotensin II receptor subtypes. Endocrinology 139 (1998) 2579-2587
16. Hoffmann J., Haendeler J., Aicher A., Rossig L., Vasa M., Zeiher A.M., et al. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res 89 (2001) 709-715
17. Imanishi T., Hano T., and Nishio I. Angiotensin II potentiates VEGF-induced proliferation, and network formation in endothelial progenitor cells. Hypertens Res 27 (2004) 101-108
18. Imanishi T., Hano T., and Nishio I. Angiotensin II accelerates endothelial progenitor cells senescence through induction of oxidative stress. J Hypertens 23 (2005) 97-104
19. Imanishi T., Hano T., and Nishio I. Estrogen reduces angiotensin II-induced acceleration of senescence in endothelial progenitor cells. Hypertens Res 28 (2005) 263-271
20. Erusalimsky J.D., and Kurz D.J. Cellular senescence in vivo: its relevance in aging and cardiovascular disease. Exp Gerontol 40 (2005) 634-642
21. Kansui Y., Fujii K., Goto K., Abe I., and Iida M. Ang II receptor antagonist improves a related endothelial dysfunction. J Hypertens 20 (2002) 439-446
22. Kuniya A., Kudej R.K., Shen Y.T., Yang G.P., Takagi G., Kudej A.B., et al. Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler Thromb Vasc Biol 20 (2000) 1493-1502
23. Kurz D.J., Decary S., Hong Y., and Erusalemsky J.D. Senescence-associated β-galactosidase reflects an increase in lysosomal mass during replicative aging of human endothelial cells. J Cell Sci 113 (2000) 3613-3622
24. Lakatta E.G. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 73 (1993) 413-467
25. Matsushita H., Chang E., Glassford A.J., Cooke J.P., Chiu C.P., and Tsao P.S. eNOS activity is reduced in senescent human endothelial cells: preservation by hTERT immortalization. Circ Res 89 (2001) 793-798
26. Minamino T., Miyauchi H., Yoshida T., Ishida Y., Yoshida H., and Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105 (2002) 1541-1544
27. Minamino T., Yoshida T., Tateno K., Miyauchi H., Zou Y., Toko H., et al. Ras induces vascular smooth muscle cell senescence and inflammation in human atherosclerosis. Circulation 108 (2003) 2264-2269
28. Minamino T., Miyauchi H., Yoshida T., Tateno K., Kunieda T., and Komuro I. Vascular cell senescence and vascular aging. J Mol Cell Cardiol 36 (2004) 175-183
29. Mukai Y., Shimokawa H., Higashi M., Morikawa K., Matoba T., Hiroki J., et al. Inhibitor renin-angiotensin system ameliorates endothelial dysfunction associated with aging in rats. Arterioscler Thromb Vasc Biol 22 (2002) 1445-1450
30. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
31. Ross R., Wight T.N., and Strandness E. Human atherosclerosis I: cell constitution and characteristics of advanced lesion of superficial femoral artery. Am J Pathol 114 (1984) 79-93
32. Schachinger V., Britten M.B., and Zeither A.M. Prognostic impact of coronary vasodilator on adverse long-term outcome of coronary heart disease. Circulation 101 (2000) 1899-1906
33. Shipley R.D., and Muller J.M. Aging decreases vasoconstrictor responses of coronary resistance arterioles through endothelium-dependent mechanisms. Cardiovasc Res 66 (2005) 374-383
34. Zeiher A.M., Drexler H., Saurbier B., and Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 92 (1993) 652-662